Drugs / LY517717
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00074828 | Dec 2003 → May 2005 | — | Eli Lilly and Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LY517717 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00074828 ↗ |
| Modality | Small molecule | — CHEMBL1271162 ↗ |
| Route | Oral | “LY517717 (a capsule given by mouth)” NCT00074828 ↗ |